Abstract-It is known that platelet MAO appears to behave more like the B-form enzyme than the A-form enzyme based on inhibitor sensitivity and substrate spec ificity. However, dog platelets showed a different substrate specificity such as high activity with 5-HT and 8-PEA as substrates. Moreover, dog platelet MAO was sensitive to the drugs clorgyline and harmaline with 5-HT as the substrate, while it was sensitive to the drug deprenyl with 8-PEA as the substrate. These results also indicate the existence of two forms of MAO in dog platelets unlike in other platelets such as those from humans. A-form MAO from dog platelets was more stable against heat treatment at 55°C than A-form MAO from dog liver and brain. On the other hand, there was no difference in the heat resistance of the three enzymes with 19-PEA as the substrate. After digestion with trypsin at 37°C for 30 min, it was found that MAO from dog platelets, brain and liver were mostly inhibited with 5-HT as the substrate. In contrast, MAO in brain and liver were inhibited about 10%, but platelet MAO was inhibited about 50% with 19-PEA as the substrate. From these results, it is considered that dog platelet MAO exists as the two forms of the enzyme and has different enzymic properties in comparison with those of MAO from dog liver and brain mitochondria.
Monoamine oxidase (MAO) occurs in many tissues (1) (2) (3) including heart, liver, kidney, spleen, platelets and the peripheral and central nervous system (4) . MAO oxidatively deaminates biogenic amines such as norepinephrine, dopamine and 5-HT (4) and may play an important role in the regu lation of the intracellular metabolism of these neurotransmitters.
Recently, alterations in activity of serotonergic and catecholamin ergic neurons have been suggested in affective disorder and schizophrenia (5) (6) (7) . In addition, alterations in platelet MAO activity in affective disorder and schizophrenia were described (8, 9) . However, there have been few studies on the possible physiological relationship between platelet MAO activity and any psychiatric diagnosis. So, it is considered necessary to investigate the enzymic properties of platelet MAO. Recently, it has been reported that human platelet MAO is a single enzyme and appears to behave more like the B-form enzyme than the A-form enzyme (10, 11). None of these inves tigations, however, provided any information about the existence of multiple forms of MAO in dog platelets. In this present study, to determine whether or not dog platelet MAO exists as the two forms of the enzyme, the substrate specificities and sensitivities to selective MAO inhibitors or trypsin and heat treatment were studied.
Materials and Methods 1. Preparation of platelets: Blood samples were obtained from a dog. After 3.8% sodium citrate was added to the sample, the blood was centrifuged at 1100 r.p.m. for 10 min to remove the red cells, and then the supernatant was centrifuged at 3000 g for 30 min. The pellet was suspended in 10 volumes of 0.01 M potassium phosphate buffer (pH 7.4). This suspension was recentrifuged at 20000 g for 30 min, and the pellet was resuspended in Table 1 . When brain and liver mitochondria from dogs were used as the enzyme preparation, the highest MAO activity was obtained with 3-PEA as the substrate, followed by tyramine and 5-HT; in platelet mitochondria, the highest MAO activity was obtained with 5-HT as a substrate.
2. Inhibition of MAO activity in dog platelet mitochondria by clorgyline and deprenyl: Inhibition of MAO in mitochondria from dog platelets by clorgyline as the A form MAO inhibitor with 5-HT as the A-form MAO substrate and inhibition by deprenyl as the B-form MAO inhibitor with 8-PEA as the B-form MAO substrate are shown in Fig. 1 . After incubation at 37°C for 60 min with clorgyline, MAO activity with 5-HT as the substrate was highly sensitive, and the activity with (3-PEA was less sensitive (Fig.  1, upper) . When corresponding experiments were performed with deprenyl, the opposite results were obtained (Fig. 1, lower) .
3. Thermal inactivation of dog platelet MAO: When dog platelets were treated at MAO activity was determined by radiometric assay. Experimental conditions were described in the Methods. Substrate concentrations used were 100 pM tyramine, 100 ,uM 5-HT and 10 pM /3-PEA as a final concentration. MAO activities were expressed as nmoles/min/mg protein. 55°C, progressive inhibition of activity was observed, and inhibition was 45% at 30 min with 5-HT as the substrate.
On the other hand, in the case of dog brain and liver, 85% and 95% inhibition were observed at 30 min, respectively. When 8-PEA was used as a substrate, the dog platelet MAO was heat labile in comparison to when 5-HT was used as the substrate (Fig. 2) .
4. Sensitivity to trypsin digestion of dog platelet MAO: Dog platelet, liver and brain mitochondria were preincubated in the presence of trypsin for various time intervals prior to determination of MAO activity. After the treatment by trypsin for 30 min, MAO activities in dog brain, liver and platelet were inhibited 85, 80%, 90% with 5-HT as the substrate, respectively (Fig. 3, upper) . On the other hand, in the case of a-PEA as the substrate, it was found that MAO activities in the dog brain and liver were lost by only 25%, but MAO activity in dog platelets remained 35% at 4 hr (Fig. 3, lower) . 
Kinetics of inhibition of dog platelet MAO by clorgyline:
The inhibitions by clorgyline of dog platelet MAO with tyramine, 5-HT and 8-PEA as substrates are shown by Lineweaver-Burk plots (Fig. 4) . The in hibition was noncompetitive, and the Km value for 5-HT was 145 /iM. As shown in Fig. 5 , the inhibitions by clorgyline of dog brain and liver MAO were also noncompeti tive. These Km values for 5-HT were 80 /cM and 145 guM, respectively. Discussion MAO is classified into two forms, A-form and B-form MAO (15-17).
It has recently been reported that MAO may exist in multiple forms depending on tissue and species (18, 19). Rat organs such as spleen and testis (20), and the neuroblastoma and glioma of mouse (21, 22) and human placenta (12, 23) contain predominantly a single species of the A-form MAO. I n contrast, B-form MAO activity is found in the mouse and rabbit liver or human platelets (11, 24). In general, it is known that the various platelet MAO's appear to behave more like the B-form enzyme than the A-form enzyme based on inhibitor sensitivity and substrate specificity (11, 24). However, dog platelet MAO showed a different substrate specificity, that is, 5-HT was also deaminated highly. Moreover, dog platelet MAO was sensitive to the drugs clorgyline and harmaline (preferentially A form MAO inhibitors) and was resistant to the drug deprenyl (preferentially a B-form MAO inhibitor) with 5-HT as the substrate. When corresponding experiments were per formed with 8-PEA (substrates for B-form MAO), the opposite results were obtained. These results also indicate the existence of two forms of MAO in dog platelets unlike in other platelets such as those from humans. A-form MAO from liver and brain. On the other hand, there were no differences in the abilities of the three enzymes to resist heat with 9-PEA as the substrate. After treatment with trypsin at 37°C for 30 min, it was found that MAO in platelets, brain and liver were mostly inhibited with 5-HT as the substrate. In contrast, MAO in brain and liver were inhibited by about 10%, but MAO in platelets was inhibited by about 50% with 8-PEA as the substrate.
From these results, A-form MAO in platelets also was heat stable and sensitive to trypsin digestion, like the A-form in other organs. These findings are in line with the results of Houslay and Tipton (27) and Ekstedt and Oreland (26) that A-form MAO is more dependent on phospholipids for its activity and that the thermostability and resistance to trypsin digestion of the enzyme are influenced by the chemical nature of the environment surrounding the enzyme protein.
Recent studies using platelet MAO activity as a possible index of central nervous system events have found altered activity of platelet MAO in depressed and schizophrenic patients (28) . In addition, Murphy and Wyatt (29) reported reduced platelet MAO activity in chronic schizophrenic individuals (30, 31). Human platelets contains solely B-form MAO (11). However, B-form MAO can not deaminate 5-HT, although 5-HT is present at high concentration in platelets. So, in the case of human platelets, we must consider the possibilities that 5-HT is me tabolized by other enzymic processes or is deaminated by a clorgyline/deprenyl insensi tive form of MAO (11 ). At present, however, dog platelet MAO deaminated 5-HT and 8-PEA, and it is sensitive to low concen trations of clorgyline and deprenyl, that is, contain also A-form and B-form MAO. We do not have any information which provides an explanation of this difference.
It seems likely that dog platelet MAO is different from other species and that it has different physiological properties. Further in vivo studies using MAO inhibitors are under way in our laboratory to elucidate the physiological function of MAO in platelets.
